Bio-Rad Laboratories (BIO) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to 0.7.
- Bio-Rad Laboratories' Equity Ratio rose 45.49% to 0.7 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.7, marking a year-over-year increase of 45.49%. This contributed to the annual value of 0.7 for FY2025, which is 45.49% up from last year.
- Per Bio-Rad Laboratories' latest filing, its Equity Ratio stood at 0.7 for Q4 2025, which was up 45.49% from 0.69 recorded in Q3 2025.
- In the past 5 years, Bio-Rad Laboratories' Equity Ratio registered a high of 37.65 during Q4 2021, and its lowest value of 0.69 during Q3 2025.
- For the 5-year period, Bio-Rad Laboratories' Equity Ratio averaged around 6.7, with its median value being 0.71 (2022).
- In the last 5 years, Bio-Rad Laboratories' Equity Ratio skyrocketed by 247680.74% in 2024 and then crashed by 9619.13% in 2025.
- Over the past 5 years, Bio-Rad Laboratories' Equity Ratio (Quarter) stood at 37.65 in 2021, then tumbled by 43.09% to 21.42 in 2022, then dropped by 17.26% to 17.73 in 2023, then tumbled by 96.04% to 0.7 in 2024, then increased by 0.45% to 0.7 in 2025.
- Its Equity Ratio was 0.7 in Q4 2025, compared to 0.69 in Q3 2025 and 0.7 in Q2 2025.